封面
市场调查报告书
商品编码
1571672

支气管切片检查设备市场规模、份额和趋势分析报告:按产品、按地区、细分市场预测,2024-2030 年

Bronchial Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Biopsy Forceps, Transbronchial Needle Aspiration Needles, Cytology Brushes, Cryobiopsy Devices), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

支气管切片检查设备市场成长与趋势:

Grand View Research, Inc.最新报告显示,预计2030年全球支气管切片检查设备市场规模将达10.2亿美元,2024年至2030年复合年增长率为7.39%。

推动市场成长的主要因素之一是越来越多地使用支气管切片检查设备来诊断呼吸系统疾病以及越来越多地采用一次性设备。此外,快速的技术进步以及对呼吸系统疾病的意识提升和筛检的提高也有助于市场的扩张。

医疗技术的进步透过提高诊断程序的准确性、安全性和有效性,显着推动了市场的成长。 EBUS-TBNA 等创新技术可以更精确地对肺组织进行采样,尤其是在难以到达的区域。与传统手术方法相比,这些微创手术可最大限度地减少患者的不适,降低併发症的风险,并缩短恢復时间。此外,公司正带着技术先进的产品进入市场,以建立强大的影响力。例如,2021年5月,Olympus扩大了产品系列,推出了用于肺癌诊断和分期的支气管内超音波(EBUS)支气管镜BF-UC190F。

此外,各机构主导的意识提升和筛检工作正在显着推动对支气管切片检查设备的需求。由于肺癌是全球发病率和死亡率最高的癌症之一,美国肺臟协会和世界卫生组织等组织正在加强努力,促进早期发现和诊断。 2024 年 8 月,为纪念世界肺癌日,以全球气喘倡议为创始成员的国际呼吸学会论坛强调,将提高人们对肺癌的认识,提供早期筛检并获得肺癌诊断和治疗。

此外,COVID-19 大流行对支气管切片检查设备市场产生了中等程度的负面影响,大流行初期观察到的肺癌诊断和治疗中断证明了这一点。根据Elsevier Espana SLU 2021年7月进行的一项研究,西班牙一家大学医院因2020年3月23日至6月21日强制隔离,肺癌诊断数量大幅减少。这一减少是由于咨询、诊断测试和非必要程序的取消和延迟,导致切片检查和筛检次数减少。

支气管切片检查设备市场报告亮点:

  • 按产品划分,经支气管针吸活检 (TBNA) 针细分市场在 2023 年占据最大收益占有率,达 62.18%,预计在预测期内将以最高复合年增长率增长。此外,切片检查设备(冷冻探针)领域预计在预测期内将显着增长。
  • 2023年,EBUS-TBNA细分市场占据最大市场占有率。 EBUS-TBNA 是一种微创技术,因为它可以从肺部和周围淋巴结中收集组织样本,而无需进行大手术。
  • 2023年,北美以超过40%的市占率主导市场。这是由于强大的医疗基础设施和创新诊断工具的日益采用。
  • 市场上的主要企业正在采取多种策略,包括联盟、合作和产品发布,以扩大其产品范围并增加市场占有率。例如,2024年5月,库克医疗在美国推出了下一代EchoTip AcuCore内视镜超音波(EUS)切片穿刺针。它与超音波视镜结合使用,用于硬膜外和黏膜下病变淋巴结、纵隔肿块和胃肠道腹膜内肿块的 FNB。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场威胁分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析
    • COVID-19 影响分析

第四章 产品经营分析

  • 2023年及2030年产品市场占有率
  • 产品细分仪表板
  • 2018-2030 年按产品分類的市场规模、预测与趋势分析
  • 切片检查钳
    • 支气管切片检查钳市场,耐用性,2018-2030
    • 一次性的
    • 可重复使用的
  • 经支气管针吸切片 (TBNA) 针
    • 经支气管针吸活检 (TBNA) 针市场,2018-2030
    • 传统的
    • EBUS-TBNA
  • 细胞学刷
    • 细胞学刷市场,2018-2030
  • 冷冻活体组织切片装置
    • 活体组织切片设备市场,耐用性,2018-2030
    • 一次性的
    • 可重复使用的

第五章 区域估计/趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析:
  • 北美洲
    • 2018-2030年北美支气管切片检查设备市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲支气管切片检查设备市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 2018-2030年亚太地区切片检查设备市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲支气管切片检查设备市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030 年中东和非洲支气管切片检查设备市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争状况

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • Medtronic
    • Boston Scientific Corporation
    • Cook Medical
    • CONMED Corporation
    • Telemed Systems, Inc.
    • HOBBS MEDICAL INC
    • Becton, Dickinson and Company(BD)
    • Olympus Corporation
    • Horizons International Corp.
    • Argon Medical Devices
    • Erbe Elektromedizin GmbH
Product Code: GVR-4-68040-126-7

Bronchial Biopsy Devices Market Growth & Trends:

The global bronchial biopsy devices market size is expected to reach USD 1.02 billion by 2030, growing at a CAGR of 7.39% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the major factors contributing to the growth of the market is the rising utilization of bronchial biopsy devices for diagnosing respiratory diseases and the increasing adoption of disposable devices. Moreover, rapid technological advancements and increasing awareness and screening regarding respiratory diseases also contribute to market expansion.

Advancements in medical technology are significantly driving the growth of the market by improving the precision, safety, and effectiveness of diagnostic procedures. Innovations such as EBUS-TBNA enable more accurate sampling of lung tissue, especially in difficult-to-reach areas. These minimally invasive techniques minimize patient discomfort, reduce the risk of complications, and shorten recovery times compared to traditional surgical methods. In addition, companies are entering the market with technologically advanced products to establish a strong presence. For instance, in May 2021, Olympus launched the BF-UC190F endobronchial ultrasound (EBUS) bronchoscope for lung cancer diagnosis and staging, thereby expanding its product portfolio.

Moreover, the increasing awareness and screening initiatives led by various organizations are significantly driving the demand for bronchial biopsy devices. With lung cancer being one of the most prevalent and deadly forms of cancer globally, organizations such as the American Lung Association and the WHO have intensified their efforts to promote early detection and diagnosis. In August 2024, in recognition of World Lung Cancer Day, the Forum of International Respiratory Societies, with the Global Initiative for Asthma as a founding member, emphasized the critical need for increased awareness, early screening, and improved access to lung cancer diagnosis & treatment.

Furthermore, the COVID-19 pandemic had a moderately negative impact on the bronchial biopsy device market, as evidenced by the disruption in lung cancer diagnosis and treatment observed during the early months of the pandemic. According to a study conducted by Elsevier Espana SLU, in July 2021, at a referral University Hospital in Spain, the mandatory confinement from March 23rd to June 21st, 2020, led to a substantial decrease in the number of lung cancer diagnoses. This decline was attributed to the cancellation or delay of medical consultations, diagnostic tests, and non-essential procedures, which resulted in a reduced number of lung biopsies & screening visits.

Bronchial Biopsy Devices Market Report Highlights:

  • Based on product, the transbronchial needle aspiration (TBNA) needles segment held the largest revenue share of 62.18% in 2023 and is expected to register growth at the highest CAGR over the forecast period. Moreover, the cryobiopsy devices (cryoprobes) segment is anticipated to grow significantly over the forecast period
  • The EBUS-TBNA segment held the largest market share in 2023, as it is a minimally invasive technique that allows for collecting tissue samples from the lungs and surrounding lymph nodes without requiring major surgery
  • In 2023, North America dominated the market with a share of over 40%, owing to the robust healthcare infrastructure and rising adoption of innovative diagnostic tools
  • Key players in the market are adopting several strategies such as partnership, collaboration, and product launch to expand their offering and increase their market share. For instance, in May 2024, Cook Medical, introduced AcuCore, a next-generation EchoTip AcuCore Endoscopic Ultrasound (EUS) Biopsy Needle in the U.S. It is employed with an ultrasound endoscope for FNB of extramural and submucosal lesions lymph nodes, mediastinal masses, and intraperitoneal masses within the GI tract

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising utilization of bronchial biopsies for diagnosing lung cancer and related conditions
      • 3.2.1.2. Rising adoption of disposable devices
      • 3.2.1.3. Rapid technological advancements
      • 3.2.1.4. Increasing awareness and screening initiatives by organizations
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Availability of alternative solutions
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Threat Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Biopsy Forceps
    • 4.4.1. Bronchial biopsy forceps market, by durability, 2018 - 2030 (USD Million)
    • 4.4.2. Disposable
      • 4.4.2.1. Disposable market, 2018 - 2030 (USD Million)
    • 4.4.3. Reusable
      • 4.4.3.1. Disposable market, 2018 - 2030 (USD Million)
  • 4.5. Transbronchial needle aspiration (TBNA) needles
    • 4.5.1. Transbronchial needle aspiration (TBNA) needles market, 2018 - 2030 (USD Million)
    • 4.5.2. Conventional
      • 4.5.2.1. Conventional market, 2018 - 2030 (USD Million)
    • 4.5.3. EBUS-TBNA
      • 4.5.3.1. EBUS-TBNA market, 2018 - 2030 (USD Million)
  • 4.6. Cytology Brushes
    • 4.6.1. Cytology brushes market, 2018 - 2030 (USD Million)
  • 4.7. Cryobiopsy Devices
    • 4.7.1. Cryobiopsy devices market, by durability, 2018 - 2030 (USD Million)
    • 4.7.2. Disposable
      • 4.7.2.1. Disposable market, 2018 - 2030 (USD Million)
    • 4.7.3. Reusable
      • 4.7.3.1. Disposable market, 2018 - 2030 (USD Million)

Chapter 5. Regional Estimates & Trend Analysis by Component

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. U.S.
      • 5.4.2.1. Key country dynamic
      • 5.4.2.2. Regulatory framework/reimbursement scenario
      • 5.4.2.3. U.S. bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Canada
      • 5.4.3.1. Key country dynamic
      • 5.4.3.2. Regulatory framework/reimbursement scenario
      • 5.4.3.3. Canada bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Mexico
      • 5.4.4.1. Key country dynamic
      • 5.4.4.2. Regulatory framework/reimbursement scenario
      • 5.4.4.3. Mexico bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key country dynamic
      • 5.5.2.2. Regulatory framework/reimbursement scenario
      • 5.5.2.3. UK bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key country dynamic
      • 5.5.3.2. Regulatory framework/reimbursement scenario
      • 5.5.3.3. Germany bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key country dynamic
      • 5.5.4.2. Regulatory framework/reimbursement scenario
      • 5.5.4.3. France bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key country dynamic
      • 5.5.5.2. Regulatory framework/reimbursement scenario
      • 5.5.5.3. Italy bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key country dynamic
      • 5.5.6.2. Regulatory framework/reimbursement scenario
      • 5.5.6.3. Spain bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Norway
      • 5.5.7.1. Key country dynamic
      • 5.5.7.2. Regulatory framework/reimbursement scenario
      • 5.5.7.3. Norway bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key country dynamic
      • 5.5.8.2. Regulatory framework/reimbursement scenario
      • 5.5.8.3. Denmark bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Sweden
      • 5.5.9.1. Key country dynamic
      • 5.5.9.2. Regulatory framework/reimbursement scenario
      • 5.5.9.3. Sweden bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key country dynamic
      • 5.6.2.2. Regulatory framework/reimbursement scenario
      • 5.6.2.3. Japan bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key country dynamic
      • 5.6.3.2. Regulatory framework/reimbursement scenario
      • 5.6.3.3. China bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key country dynamic
      • 5.6.4.2. Regulatory framework/reimbursement scenario
      • 5.6.4.3. India bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key country dynamic
      • 5.6.5.2. Regulatory framework/reimbursement scenario
      • 5.6.5.3. South Korea bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. Australia
      • 5.6.6.1. Key country dynamic
      • 5.6.6.2. Regulatory framework/reimbursement scenario
      • 5.6.6.3. Australia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key country dynamic
      • 5.6.7.2. Regulatory framework/reimbursement scenario
      • 5.6.7.3. Thailand bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key country dynamic
      • 5.7.2.2. Regulatory framework/reimbursement scenario
      • 5.7.2.3. Brazil bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key country dynamic
      • 5.7.3.2. Regulatory framework/reimbursement scenario
      • 5.7.3.3. Argentina bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. MEA bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key country dynamic
      • 5.8.2.2. Regulatory framework/reimbursement scenario
      • 5.8.2.3. South Africa bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key country dynamic
      • 5.8.3.2. Regulatory framework/reimbursement scenario
      • 5.8.3.3. Saudi Arabia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key country dynamic
      • 5.8.4.2. Regulatory framework/reimbursement scenario
      • 5.8.4.3. UAE bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key country dynamic
      • 5.8.5.2. Regulatory framework/reimbursement scenario
      • 5.8.5.3. Kuwait bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. Medtronic
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Boston Scientific Corporation
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Cook Medical
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. CONMED Corporation
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Telemed Systems, Inc.
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. HOBBS MEDICAL INC
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. Becton, Dickinson and Company (BD)
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Olympus Corporation
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Horizons International Corp.
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Argon Medical Devices
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Erbe Elektromedizin GmbH
      • 6.5.11.1. Overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 4. North America bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 5. North America bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 6. U.S. bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 7. Canada bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 8. Mexico bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 9. Europe bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 10. UK bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 11. Germany bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 12. France bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 13. Italy bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 14. Spain bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 15. Norway bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 16. Denmark bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 17. Sweden bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 18. Asia Pacific bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 19. Asia Pacific bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 20. Japan bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 21. China bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 22. India bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 23. Australia bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 24. South Korea bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 25. Thailand bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 26. Latin America bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 27. Latin America bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 28. Brazil bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 29. Argentina bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 30. Middle East & Africa bronchial biopsy devices market, by country, 2018 - 2030 (USD Million)
  • Table 31. Middle East & Africa bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 32. South Africa bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 33. Saudi Arabia bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 34. UAE bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 35. Kuwait bronchial biopsy devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1. Market research process
  • Fig. 2. Information procurement
  • Fig. 3. Primary research pattern
  • Fig. 4. Market research approaches
  • Fig. 5. Value chain-based sizing & forecasting
  • Fig. 6. Market formulation & validation
  • Fig. 7. Market segmentation
  • Fig. 8. Market snapshot
  • Fig. 9. Segment snapshot
  • Fig. 10. Competitive landscape snapshot
  • Fig. 11. Market trends & outlook
  • Fig. 12. PESTLE analysis
  • Fig. 13. Porter's five forces analysis
  • Fig. 14. Bronchial biopsy devices market: Product outlook and key takeaways
  • Fig. 15. Bronchial biopsy devices market: Product movement analysis
  • Fig. 16. Biopsy forceps market, 2018 - 2030 (USD Million)
  • Fig. 17. Disposable biopsy forceps market, 2018 - 2030 (USD Million)
  • Fig. 18. Reusable biopsy forceps market, 2018 - 2030 (USD Million)
  • Fig. 19. Transbronchial needle aspiration (TBNA) needles market, 2018 - 2030 (USD Million)
  • Fig. 20. Conventional market, 2018 - 2030 (USD Million)
  • Fig. 21. EBUS-TBNA market, 2018 - 2030 (USD Million)
  • Fig. 22. Cytology brushes market, 2018 - 2030 (USD Million)
  • Fig. 23. Cryobiopsy devices (cryoprobes) market, 2018 - 2030 (USD Million)
  • Fig. 24. Disposable cryobiopsy devices (cryoprobes) market, 2018 - 2030 (USD Million)
  • Fig. 25. Reusable cryobiopsy devices (cryoprobes) market, 2018 - 2030 (USD Million)
  • Fig. 26. Regional marketplace: Key takeaways
  • Fig. 27. Regional outlook, 2023 & 2030
  • Fig. 28. Bronchial biopsy devices market : Region movement analysis
  • Fig. 29. North America bronchial biopsy devices market , 2018 - 2030 (USD Million)
  • Fig. 30. U.S. bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 31. Key country dynamics
  • Fig. 32. Canada bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 33. Key country dynamics
  • Fig. 34. Mexico bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 35. Key country dynamics
  • Fig. 36. Europe bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 37. UK bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 38. Key country dynamics
  • Fig. 39. Germany bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 40. Key country dynamics
  • Fig. 41. France bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 42. Key country dynamics
  • Fig. 43. Italy bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 44. Key country dynamics
  • Fig. 45. Spain bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 46. Key country dynamics
  • Fig. 47. Spain bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 48. Key country dynamics
  • Fig. 49. Norway bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 50. Key country dynamics
  • Fig. 51. Denmark bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 52. Key country dynamics
  • Fig. 53. Sweden bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 54. Key country dynamics
  • Fig. 55. Asia Pacific bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 56. Japan bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 57. Key country dynamics
  • Fig. 58. China bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 59. Key country dynamics
  • Fig. 60. India bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 61. Key country dynamics
  • Fig. 62. Australia bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 63. Key country dynamics
  • Fig. 64. South Korea bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 65. Key country dynamics
  • Fig. 66. Thailand bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 67. Key country dynamics
  • Fig. 68. Latin America bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 69. Brazil bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 70. Key country dynamics
  • Fig. 71. Argentina bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 72. Key country dynamics
  • Fig. 73. Middle East and Africa bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 74. South Africa bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 75. Key country dynamics
  • Fig. 76. Saudi Arabia bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 77. Key country dynamics
  • Fig. 78. UAE bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 79. Key country dynamics
  • Fig. 80. Kuwait bronchial biopsy devices market, 2018 - 2030 (USD Million)
  • Fig. 81. Key country dynamics
  • Fig. 82. Company categorization
  • Fig. 83. Strategy mapping
  • Fig. 84. Company market position analysis